Physician profile
Brittany Scribner
NPI 1306415237
$1,054.07
in general payments reported to CMS, 2019-2025
22 companies · $34.04 in 2025
The $34.04 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.23 · 2022: $136 · 2023: $440 · 2024: $409 · 2025: $34.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $158.54 | 2023-2024 | Krystexxa, Enbrel, Otezla |
| Glaxosmithkline, LLC. | $149.28 | 2022-2024 | Benlysta |
| Novartis Pharmaceuticals Corporation | $129.53 | 2023-2025 | |
| Abbvie INC. | $97.58 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $89.32 | 2023-2024 | Orencia |
| Janssen Biotech, INC. | $62.34 | 2022-2024 | Tremfya |
| Ani Pharmaceuticals, INC. | $39.46 | 2023 | Purified Cortrophin Gel |
| Horizon Therapeutics Plc | $37.72 | 2023 | Krystexxa |
| Genzyme Corporation | $36.42 | 2022 | |
| Lilly USA, LLC | $33.86 | 2023-2024 | Taltz |
| Ucb, INC. | $32.48 | 2023 | Cimzia |
| Lundbeck LLC | $23.01 | 2023 | Vyepti |
| Regeneron Healthcare Solutions, INC. | $21.39 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.56 | 2021 | |
| Organon LLC | $17.76 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $16.40 | 2022 | |
| Philips North America LLC | $15.74 | 2022 | |
| Biogen, INC. | $15.67 | 2021 | |
| Sandoz INC. | $15.22 | 2023 | Hyrimoz |
| Fresenius Kabi USA, LLC | $15.02 | 2023 | Idacio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.40 | 2023 | Cyltezo |
| Astrazeneca Pharmaceuticals LP | $14.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Scribner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.